Xarelto Bellwether Loser Says New Study Merits Retrial
A woman who lost a federal bellwether trial on claims that Janssen Pharmaceuticals' and Bayer's blood thinner Xarelto caused her hospitalization for internal bleeding has moved for a new trial, arguing...To view the full article, register now.
Already a subscriber? Click here to view full article